DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Boston Convention and Exhibition Center

2013年6月23日 (日) 午前 8:30 - 2013年6月27日 (木) 午後 12:45

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

eSource Symposium

Session Chair(s)

Chris  Ramm

Chris Ramm

Clinical Ink, United States

A Common Tool for Investigator Site eSource (EHRS) Readiness Assessment

Learning Objective : Discuss the principles of risk-based approaches to successfully using esource clinical data; Identify how to implement a risk-based study monitoring approach to electronic clinical data; Describe methods to successfully assess electronic health records systems that will be used for clinical data.

Speaker(s)

Catherine  Celingant, MA

A Common Tool for Investigator Site eSource (EHRS) Readiness Assessment

Catherine Celingant, MA

Pfizer Inc, United States

Executive Director, Data Monitoring and Management, Oncology Therapeutics Lead

Chris  Ramm

Chris Ramm

Clinical Ink, United States

Jules  Mitchel, PHD, MBA

Time to Change the Clinical Trial Monitoring Paradigm: Results From Clinical Trials Using eSource and Risk-based Monitoring

Jules Mitchel, PHD, MBA

THI Pharma Services, United States

President and CEO

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。